🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Endurance Training in Sickle Cell Disease Patients: Impact on Clinical Profile, Physical Fitness, and Quality of Life.

RecruitingNAAges 15 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT06823219 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Sickle cell disease (SCD), the most common genetic disease worldwide and in France, is an inherited haemoglobinopathy characterised by chronic haemolytic anaemia, vaso-occlusive crisis (VOC), acute pain, and multi-organ damage. Due to anaemia and multiple pulmonary, cardiac, endothelial, muscle, and metabolic dysfunctions, fatigue and poor physical capacity are common in SCD patients and constitute the primary reason for a sedentary lifestyle. However, recent findings demonstrated in the first randomised, controlled, and prospective study implementing endurance training in SCD that, when adequately calibrated, regular moderate-intensity endurance training is not only safe but also beneficial for patients (primary outcome: improvement of physical ability). This pivotal randomised, controlled, prospective study is designed to prove, on a large multicentre cohort, adult and paediatric, in

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged over 15 years and 3 months * Male or female * Patients with sickle cell disease (HbSS or HbS-βthal0) * Affiliated to a social security system * Having freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved * Patients in stabilised condition at the start of the experiment: at least 1 month after an acute chronic event or at least 3 months after a blood transfusion. * Patients hospitalised for vaso-occlusive crisis at least once in the last 3 years Exclusion Criteria: * Patient whose adherence to the protocol is unlikely according to the investigator * Patients who already partake in regular physical activity (more than 1 hour of moderate-intensity physical activity per week) * Patients with a chronic inflammatory and/or infectious pathology * Patients with an intercurrent condition unresolved for less than a month * Patients hospitalised for cardiac decompensation during the last 12 months * Patients on anticoagulant treatment or with a pacemaker/defibrillator * Pregnant patients / breastfeeding woman * Patients deprived of liberty by judicial or administrative decision or patient under guardianship * Patients unable to understand the objectives and conditions of the study and unable to give cons
💊

What it tests

  • endurance training program
📍

Where

1 site
Henri Mondor Hospital
Créteil, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy